Meritage Portfolio Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Sell |
47,579
-460
| -1% | -$9.98K | 0.07% | 189 |
|
|
2025
Q1 | $1.16M | Buy |
48,039
+1,949
| +4% | +$47.3K | 0.08% | 184 |
|
|
2024
Q4 | $962K | Buy |
46,090
+3,176
| +7% | +$66.3K | 0.06% | 201 |
|
|
2024
Q3 | $853K | Buy |
42,914
+23,554
| +122% | +$468K | 0.05% | 216 |
|
|
2024
Q2 | $300K | Buy |
19,360
+213
| +1% | +$3.3K | 0.02% | 295 |
|
|
2024
Q1 | $305K | Buy |
+19,147
| New | +$305K | 0.02% | 293 |
|
|
2023
Q1 | – | Sell |
-10,485
| Closed | -$195K | – | 317 |
|
|
2022
Q4 | $195K | Buy |
+10,485
| New | +$195K | 0.02% | 303 |
|